Major research interest of the group is the genomic landscape of head and neck cancer, with a particular focus on understanding the mechanisms driving lymph nodes metastasis of these tumors. In parallel, we are exploring intervention protocols that combine cellular immunotherapies consisting of anti-tumor chimeric antigen receptors along with radiation therapy.
